Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21959830 | 0.80 | LMNA (0.30) | — | |
| SCHEMBL4071967 | 0.78 | — | — | |
| SCHEMBL22711430 | 0.76 | MAOB (0.38) | MAPT | |
| SCHEMBL2976498 | 0.75 | — | — | |
| SCHEMBL15980355 | 0.73 | HTR2A (0.39) | MAPT | |
| SCHEMBL9667488 | 0.71 | THRA (0.40) | MAPT | |
| SCHEMBL22711501 | 0.70 | APP (0.47) | — | |
| SCHEMBL2370519 | 0.69 | MAPK1 (0.54) | MAPT | |
| SCHEMBL25331052 | 0.68 | CYP2A6 (0.47) | — | |
| SCHEMBL755670 | 0.68 | HTR7 (0.53) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612474-B2 | Bis(heterocyclic-olate) Lewis base catalysts and methods thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2026-04-28 | — | — | US | disclosed |
| US-20250353939-A1 | Bis(heterocyclic-olate) Lewis Base Catalysts and Methods Thereof | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2025-11-20 | — | — | US | disclosed |
| EP-4222180-B1 | BIS(HETEROCYCLIC-OLATE) LEWIS BASE CATALYSTS AND METHODS THEREOF | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-4222180-A1 | BIS(HETEROCYCLIC-OLATE) LEWIS BASE CATALYSTS AND METHODS THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2023-08-09 | — | — | EP | disclosed |
| CN-116323694-A | Bis (heterocyclic-alkoxide) lewis base catalysts and methods thereof | 埃克森美孚化学专利公司 | 2023-06-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12612474-B2 | Bis(heterocyclic-olate) Lewis base catalysts and methods thereof | CBR1, PBRM1, NOX1 | MAPT 4741/4885 |
| US-20250353939-A1 | Bis(heterocyclic-olate) Lewis Base Catalysts and Methods Thereof | RPL13, PARG, POLI | MAPT 3868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.